66 With $1.3 Million. Here Are 3 Hidden Gems to Target

BMY's 17 consecutive dividend raises and VZ's $20B in annual free cash flow make both the dependable income anchors of this trio.

Pfizer's free cash flow covered only 93% of its 2025 dividends, its first shortfall since 2023, putting its 6.6% yield on close watch.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Verizon didn't make the cut. Grab the names FREE today.

At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000 a year before Social Security. The cash flow underneath these three blue chips is what matters most for a retiree. I dug into each dividend to see which ones a 66-year-old can actually rely on.

Bristol Myers Squibb (NYSE:BMY) just raised its payout for a 17th consecutive year, backed by 94 straight years of dividend payments.

The Growth Portfolio rose 12% to $6.23B in Q1 2026, with Eliquis up 16% and Camzyos up 97%. CEO Christopher Boerner said BMY is "off to a good start in 2026, with first quarter results reflecting sustained momentum." The Legacy book is shrinking 12% to 16% on generics, but a 41% payout leaves real cushion.

Verdict: Safe. Bull case: Growth Portfolio offsets t

Fuente original: Yahoo Finance (https://finance.yahoo.com/markets/stocks/articles/66-1-3-million-3-145103416.html)